Spruson & Ferguson has an established practice in the biotechnology, pharmaceutical and life sciences industries.

Our patent attorneys are technically qualified in areas including genetics, biophysics, molecular biology, microbiology, biomedical engineering, chemistry and biochemistry with the majority qualified to PhD level.

With our strong network of offices across the Asia-Pacific, we are well placed to assist clients with their patent portfolios in this rapidly expanding industry.

Key Team Members View More
Beijing, China
Dr. Oliver Lutze
Principal, China Country Manager
Patents: Chemical & Life Science
+86 10 8225 5655 oliver.lutze@spruson.com
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent matters with a special focus on China activities. Oliver’s practice primarily…
Oliver Lutze is Spruson & Ferguson’s Country Manager for China. He is based in Beijing and advises on patent…
Read More
Sydney, Australia
Dr. Simon Potter
Principal, Chemical / Life Sciences Leader Australia
Patents: Chemical & Life Science
+61 2 9393 0100 simon.potter@spruson.com
Simon is an experienced patent attorney specialising in biotechnology. As head of Spruson & Ferguson’s Chemical/Life Sciences team in Australia, he assists clients in all aspects of patent practice…
Simon is an experienced patent attorney specialising in biotechnology. As head of Spruson & Ferguson’s Chemical/Life Sciences team in…
Read More
Singapore, Singapore
Choo Chiou Yu
Principal, Director Singapore, Chemical / Life Sciences Leader Asia
Patents: Chemical & Life Science
+65 6333 7200 chiouyu.choo@spruson.com
Chiou Yu is Head of the Chemical/Life Sciences team in Asia and is a registered Singapore patent attorney. Chiou Yu has extensive experience in patent practice in Asia…
Chiou Yu is Head of the Chemical/Life Sciences team in Asia and is a registered Singapore patent attorney. …
Read More

Proud Partners of

Latest News & Insights
Biological deposits under the Budapest Treaty
In order to obtain patent protection in Australia, an invention must be novel, involve an inventive step and have industrial applicability. There is also a disclosure and enablement requirement…
In order to obtain patent protection in Australia, an invention must be novel, involve an inventive step and have…
Read More
Coronavirus the global pandemic: a guide to patenting
COVID-19 (short for coronavirus disease 2019) is caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more commonly referred to as coronavirus. Coronavirus has dominated world headlines in 2020, leading to nationwide…
COVID-19 (short for coronavirus disease 2019) is caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more commonly referred to…
Read More
Conference poster presentations as prior art for the assessment of novelty of a later patent application
Conferences are an important way for scientists and researchers to share and promote their research. They typically include poster presentation sessions where researchers present their findings. Conferences help generate interest in the scientific community…
Conferences are an important way for scientists and researchers to share and promote their research. They typically include poster presentation sessions…
Read More
Diagnostic Methods in Australia
In Sequenom, Inc. v Ariosa Diagnostics, Inc. FCA 1011, the Federal Court confirmed that diagnostic methods are patentable subject-matter in Australia. This will be a satisfying result for…
In Sequenom, Inc. v Ariosa Diagnostics, Inc. FCA 1011, the Federal Court confirmed that diagnostic methods are patentable…
Read More

Contact our Expert Team

Contact Us